Spiro derivatives as lipoxygenase inhibitors
The present invention is concerned with certain novel spiro substituted heterocylic ring derivatives. These compounds may be useful in the manufacture of pharmaceutical compositions for treating disorders mediated by lipoxygenases. They may also be useful in the manufacture of pharmaceutical formulations for the treatment of lipoxygenase-mediated disorders.
Eli Lilly and Company
A A A A C A A A A A C A A A A A A A A A A A A A A A A C C C C A C C C C A A A A A
A61P A61P A61P A61P C07D A61P A61P A61P A61P A61P C07D A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P C07D C07D C07D C07D A61P C07D C07D C07D C07D A61P A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Jian Bing Donald R. Daniel T. W. Wei Xianfeng Jiangao Qiang
Chen Wang James Chu Zhang Li Song Cong